Real-time enrollment status for this hematologic malignancy clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 12:38 AM UTC
| NCT Number | NCT07052370 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancy |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | St. Jude Children's Research Hospital |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 21, 2026: Clinical trial NCT07052370 is currently recruiting participants. This phase1 study for hematologic malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by St. Jude Children's Research Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07052370 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07052370 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.